| Net revenues | 156.88a | 189.54a | 179.59a |
| Cost of revenues | -136.36a | -151.4a | -144.33a |
| Selling, general and other costs | -9.3a | -9.54a | -8.98a |
| Research and development costs | -5.78a | -5.62a | -5.2a |
| Gains/(losses) on disposal of investments | -0.1a | 0.02a | 0.07a |
| Restructuring costs | -1.62a | -1.12a | -1.14a |
| Share of the profit/(loss) of equity method investees | -0.03a | 0.49a | 0.26a |
| Operating income/(loss) | 3.69a | 22.38a | 20.28a |
| Net financial expenses/(income) | -0.35a | -0.04a | 0.77a |
| Profit/(loss) before taxes | 4.03a | 22.42a | 19.51a |
| Tax expenses/(benefit) | -1.49a | 3.79a | 2.73a |
| Net profit/(loss) | 5.52a | 18.63a | 16.78a |
| Net profit/(loss) attributable to | — | — | — |
| Owners of the parent | 5.47a | 18.6a | 16.8a |
| Non-controlling interests | 0.05a | 0.03a | -0.02a |